Rafael Fonseca

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 40

Top Topics

Multiple Myeloma

Tyrosine Kinase

Top Venues

Blood cancer journal

Future oncology (London, England)

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Ghulam Rehman Mohyuddin, Samuel M Rubinstein, Shaji K Kumar, Sundararajan Vincent Rajkumar, Rafael Fonseca, Nadine H Abdallah, Gregory Sampang Calip, Xiaoyan Wang, Christina M Parrinello, Douglas Sborov
Performance of newer myeloma staging systems in a contemporary, large patient cohort. Blood cancer journal 14 (1) (2024)
Hira S Mian, Martin F Kaiser, Rafael Fonseca
Translocation t(14;16) in multiple myeloma: gangster or just part of the gang? Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Ghulam Rehman Mohyuddin, Samuel M Rubinstein, Shaji K Kumar, Sundararajan Vincent Rajkumar, Rafael Fonseca, Nadine H Abdallah, Gregory Sampang Calip, Xiaoyan Wang, Christina M Parrinello, Douglas Sborov
Performance of newer myeloma staging systems in a contemporary, large patient cohort. Blood cancer journal 14 (1) (2024)
Hira S Mian, Martin F Kaiser, Rafael Fonseca
Translocation t(14;16) in multiple myeloma: gangster or just part of the gang? Blood cancer journal 14 (1) (2024)
Alex Wonnaparhown, Talal Hilal, Jacqueline Squire, Catherine Freeman, Rafael Fonseca
IgG replacement in multiple myeloma. Blood cancer journal 14 (1) (2024)
Hira S Mian, Martin F Kaiser, Rafael Fonseca
Translocation t(14;16) in multiple myeloma: gangster or just part of the gang? Blood cancer journal 14 (1) (2024)
Rafael Fonseca, Adriana Rossi, Rohan Medhekar, Jennifer Voelker, Trevor Homan, Jessica Wilcock, Anna Karakusevic, James Cochrane, Daisy Bridge, Richard Perry, Shuchita Kaila, Faith E Davies
Clinical consensus on treatments for transplant-ineligible newly diagnosed multiple myeloma: double-blinded Delphi panel. Future oncology (London, England) (2024)
Hira S Mian, Martin F Kaiser, Rafael Fonseca
Translocation t(14;16) in multiple myeloma: gangster or just part of the gang? Blood cancer journal 14 (1) (2024)
Ghulam Rehman Mohyuddin, Samuel M Rubinstein, Shaji K Kumar, Sundararajan Vincent Rajkumar, Rafael Fonseca, Nadine H Abdallah, Gregory Sampang Calip, Xiaoyan Wang, Christina M Parrinello, Douglas Sborov
Performance of newer myeloma staging systems in a contemporary, large patient cohort. Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Ghulam Rehman Mohyuddin, Samuel M Rubinstein, Shaji K Kumar, Sundararajan Vincent Rajkumar, Rafael Fonseca, Nadine H Abdallah, Gregory Sampang Calip, Xiaoyan Wang, Christina M Parrinello, Douglas Sborov
Performance of newer myeloma staging systems in a contemporary, large patient cohort. Blood cancer journal 14 (1) (2024)
Hira S Mian, Martin F Kaiser, Rafael Fonseca
Translocation t(14;16) in multiple myeloma: gangster or just part of the gang? Blood cancer journal 14 (1) (2024)
Alex Wonnaparhown, Talal Hilal, Jacqueline Squire, Catherine Freeman, Rafael Fonseca
IgG replacement in multiple myeloma. Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Rafael Fonseca, Adriana Rossi, Rohan Medhekar, Jennifer Voelker, Trevor Homan, Jessica Wilcock, Anna Karakusevic, James Cochrane, Daisy Bridge, Richard Perry, Shuchita Kaila, Faith E Davies
Clinical consensus on treatments for transplant-ineligible newly diagnosed multiple myeloma: double-blinded Delphi panel. Future oncology (London, England) (2024)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Hira S Mian, Tanya M Wildes, Christopher P Venner, Rafael Fonseca
MRD negativity: considerations for older adults with multiple myeloma. Blood cancer journal 13 (1) (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Radhika Bansal, Mizba Baksh, Jeremy T Larsen, Matthew A Hathcock, David Dingli, A Keith Stewart, Prashant Kapoor, Taxiarchis V Kourelis, Suzanne R Hayman, Rahma M Warsame, Rafael Fonseca, Peter Leif Bergsagel, Sikandar Ailawadhi, Shaji K Kumar, Yi Lin
Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma. Blood cancer journal 13 (1) (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Nadine H Abdallah, Moritz Binder, Sundararajan Vincent Rajkumar, Patricia T Greipp, Prashant Kapoor, Angela Dispenzieri, Morie A Gertz, Linda B Baughn, Martha Q Lacy, Suzanne R Hayman, Francis K Buadi, David Dingli, Ronald S Go, Yi L Hwa, Amie L Fonder, Miriam A Hobbs, Yi Lin, Nelson Leung, Taxiarchis V Kourelis, Rahma Warsame, Mustaqeem A Siddiqui, Robert A Kyle, Peter Leif Bergsagel, Rafael Fonseca, Rhett P Ketterling, Shaji K Kumar
A simple additive staging system for newly diagnosed multiple myeloma. Blood cancer journal 12 (1) (2022)
Ricardo D Parrondo, Zaid Abdel Rahman, Michael G Heckman, Mikolaj Wieczorek, Liuyan Jiang, Hassan B Alkhateeb, Mark R Litzow, Patricia Greipp, Taimur Sher, Peter Leif Bergsagel, Rafael Fonseca, Vivek Roy, Angela Dispenzieri, Mohamed A Kharfan-Dabaja, Hemant S Murthy, Sikandar Ailawadhi, James M Foran
Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma. Blood cancer journal 12 (6) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Sandeep S Voleti, Rahma M Warsame, Carolyn Mead-Harvey, Sikandar Ailawadhi, Atul Jain, Rafael Fonseca, Joan M Griffin, Nandita Khera
Assessing Patient-Reported Financial Hardship in Patients With Cancer in Routine Clinical Care. JCO oncology practice 18 (11) (2022)
Saurabh Zanwar, Matthew Ho, Francis K Buadi, Sikandar Ailawadhi, Jeremy Larsen, Peter Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Rafael Fonseca, Morie A Gertz, Wilson Gonsalves, Ronald S Go, Suzanne Hayman, Prashant Kapoor, Taxiarchis V Kourelis, Martha Q Lacy, Nelson Leung, Yi Lin, Eli Muchtar, Vivek Roy, Taimur Sher, Rahma Warsame, Amie Fonder, Miriam Hobbs, Yi L Hwa, Robert A Kyle, Sundararajan Vincent Rajkumar, Shaji K Kumar
Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy. Blood cancer journal 12 (11) (2022)
Timothy Martin Schmidt, Rafael Fonseca, Saad Z Usmani
Chromosome 1q21 abnormalities in multiple myeloma. Blood cancer journal 11 (4) (2021)
Rafael Fonseca, May Hagiwara, Sumeet Panjabi, Emre Yucel, Jacqueline Buchanan, Thomas Delea
Economic burden of disease progression among multiple myeloma patients who have received transplant and at least one line of therapy in the US. Blood cancer journal 11 (2) (2021)
Vikram J Premkumar, Suzanne Lentzch, Samuel Pan, Divaya Bhutani, Joshua Richter, Sundar Jagannath, Michaela Liedtke, Arnaud Jaccard, Ashutosh D Wechalekar, Raymond Comenzo, Vaishali Sanchorawala, Bruno Royer, Michael Rosenzweig, Jason Valent, Stefan O Schönland, Rafael Fonseca, Sandy Wong, Prashant Kapoor
Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis. Blood cancer journal 11 (1) (2021)
Luke Mountjoy, Sinto Sebastian, Tania Jain, Talal Hilal, Miguel Gonzalez-Velez, Marlene Girardo, Greg Ahmann, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Prediction of immunomodulatory drugs (IMiDs) sensitivity in myeloma via determination of baseline anti-oxidative stress capacity. Leukemia 34 (11) (2020)